32 WIGGINS AVENUE, BEDFORD, MA
Sixth Amendment to Anika Therapeutics 2017 Omnibus Incentive Plan Approved
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results
Announces Leadership Transition
Reports Third Quarter 2025 Financial Results
Reports Second Quarter 2025 Financial Results
Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence
S-8 POS